Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DAWNNASDAQ:FLYW On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDAWNDay One Biopharmaceuticals$7.62-2.1%$8.00$6.41▼$18.00$772.32M-1.241.05 million shs1.28 million shsFLYWFlywire$9.57+1.7%$9.77$8.20▼$23.40$1.18B1.221.74 million shs1.40 million shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDAWNDay One Biopharmaceuticals-2.06%-3.54%+0.13%-38.40%-56.92%FLYWFlywire+1.70%+8.50%+0.10%-50.49%-53.09%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDAWNDay One Biopharmaceuticals2.5326 of 5 stars4.60.00.00.02.72.50.0FLYWFlywire4.1303 of 5 stars4.13.00.00.03.33.31.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDAWNDay One Biopharmaceuticals 3.13Buy$32.29323.70% UpsideFLYWFlywire 2.25Hold$17.0077.64% UpsideCurrent Analyst Ratings BreakdownLatest FLYW and DAWN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/23/2025FLYWFlywireWolfe ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Peer Perform4/14/2025FLYWFlywireJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Underweight$16.00 ➝ $9.004/3/2025DAWNDay One BiopharmaceuticalsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$36.00 ➝ $36.004/2/2025FLYWFlywireThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$15.00 ➝ $11.003/25/2025DAWNDay One BiopharmaceuticalsThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$39.00 ➝ $27.003/24/2025FLYWFlywireCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$26.00 ➝ $13.003/5/2025DAWNDay One BiopharmaceuticalsJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$39.00 ➝ $34.002/26/2025DAWNDay One BiopharmaceuticalsWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$32.00 ➝ $32.002/26/2025DAWNDay One BiopharmaceuticalsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$32.00 ➝ $32.002/26/2025DAWNDay One BiopharmaceuticalsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$40.00 ➝ $36.002/26/2025FLYWFlywireRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$25.00 ➝ $20.00(Data available from 5/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDAWNDay One Biopharmaceuticals$131.16M5.89N/AN/A$3.98 per share1.91FLYWFlywire$492.14M2.40$0.04 per share255.58$6.41 per share1.49Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDAWNDay One Biopharmaceuticals-$188.92M-$1.08N/AN/AN/AN/A-22.40%-19.79%5/6/2025 (Estimated)FLYWFlywire-$8.57M$0.0263.8038.281.414.23%2.49%1.86%5/6/2025 (Estimated)Latest FLYW and DAWN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/6/2025Q1 2025DAWNDay One Biopharmaceuticals-$0.45N/AN/AN/A$30.28 millionN/A5/6/2025Q1 2025FLYWFlywire$0.01N/AN/AN/A$124.18 millionN/A2/25/2025Q4 2024DAWNDay One Biopharmaceuticals-$0.35-$0.69-$0.34-$0.69$27.11 million$29.21 million2/25/2025Q4 2024FLYWFlywire-$0.01-$0.12-$0.11-$0.12$118.85 million$112.80 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDAWNDay One BiopharmaceuticalsN/AN/AN/AN/AN/AFLYWFlywireN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDAWNDay One BiopharmaceuticalsN/A14.6214.55FLYWFlywireN/A2.332.33Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDAWNDay One Biopharmaceuticals87.95%FLYWFlywire95.90%Insider OwnershipCompanyInsider OwnershipDAWNDay One Biopharmaceuticals6.20%FLYWFlywire3.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDAWNDay One Biopharmaceuticals60101.35 million92.38 millionOptionableFLYWFlywire660123.59 million119.57 millionOptionableFLYW and DAWN HeadlinesRecent News About These CompaniesAdage Capital Partners GP L.L.C. Purchases 108,062 Shares of Flywire Co. (NASDAQ:FLYW)May 2 at 4:46 AM | marketbeat.comFlywire (FLYW) to Release Quarterly Earnings on TuesdayMay 1 at 8:23 AM | marketbeat.comEmerald Mutual Fund Advisers Trust Purchases 74,248 Shares of Flywire Co. (NASDAQ:FLYW)May 1 at 7:23 AM | marketbeat.comFlywire and Avanse Financial Services Announce Strategic Partnership to Digitize Student Loan Disbursements from IndiaApril 30 at 9:00 AM | globenewswire.comT. Rowe Price Investment Management Inc. Acquires New Shares in Flywire Co. (NASDAQ:FLYW)April 30 at 5:29 AM | marketbeat.comFlywire Corporation (FLYW): Among the Oversold Tech Stocks to Buy According to Hedge FundsApril 29 at 3:32 PM | msn.comFlywire Corporation (FLYW): Among the Oversold Tech Stocks to Buy According to Hedge Funds (READY TO EDIT1)April 29 at 3:32 PM | msn.comDark Forest Capital Management LP Acquires Shares of 29,820 Flywire Co. (NASDAQ:FLYW)April 28, 2025 | marketbeat.comFlywire Co. (NASDAQ:FLYW) Shares Purchased by North Reef Capital Management LPApril 27, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Flywire Corporation – FLYWApril 25, 2025 | globenewswire.comFlywire's (FLYW) "Peer Perform" Rating Reiterated at Wolfe ResearchApril 25, 2025 | marketbeat.comRussell Investments Group Ltd. Purchases 29,710 Shares of Flywire Co. (NASDAQ:FLYW)April 25, 2025 | marketbeat.comFlywire downgraded to Peer Perform from Outperform at Wolfe ResearchApril 24, 2025 | markets.businessinsider.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Flywire Corporation - FLYWApril 24, 2025 | accessnewswire.comFlywire Co. (NASDAQ:FLYW) Receives $17.00 Consensus Price Target from BrokeragesApril 24, 2025 | americanbankingnews.comWolfe Research Downgrades Flywire (FLYW)April 23, 2025 | msn.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Flywire Corporation - FLYWApril 23, 2025 | accessnewswire.comVoss Capital LP Invests $30.62 Million in Flywire Co. (NASDAQ:FLYW)April 23, 2025 | marketbeat.comMarshall Wace LLP Sells 714,895 Shares of Flywire Co. (NASDAQ:FLYW)April 23, 2025 | marketbeat.com28,363 Shares in Flywire Co. (NASDAQ:FLYW) Acquired by XTX Topco LtdApril 22, 2025 | marketbeat.comRenaissance Technologies LLC Buys 189,521 Shares of Flywire Co. (NASDAQ:FLYW)April 22, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeFLYW and DAWN Company DescriptionsDay One Biopharmaceuticals NASDAQ:DAWN$7.62 -0.16 (-2.06%) Closing price 05/1/2025 04:00 PM EasternExtended Trading$7.66 +0.04 (+0.51%) As of 07:03 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.Flywire NASDAQ:FLYW$9.57 +0.16 (+1.70%) Closing price 05/1/2025 04:00 PM EasternExtended Trading$9.62 +0.04 (+0.47%) As of 05:20 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Flywire Corporation, together with its subsidiaries, operates as a payments enablement and software company in the United States and internationally. Its payment platform and network, and vertical-specific software help clients to get paid and help their customers to pay. The company's platform facilitates payment flows across multiple currencies, payment types, and payment options, as well as provides direct connections to alternative payment methods, such as Alipay, Boleto, PayPal/Venmo, and Trustly. It serves education, healthcare, travel, and business to business organizations. The company was formerly known as peerTransfer Corporation and changed its name to Flywire Corporation in December 2016. Flywire Corporation was incorporated in 2009 and is headquartered in Boston, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Microsoft Crushes Earnings, What’s Next for MSFT Stock? 3 Biotech Giants Gaining From U.S. Sales and Policy Shifts McDonald’s Insiders Sell Shares! Investors Should Do the Opposite Qualcomm's Earnings: 2 Reasons to Buy, 1 to Stay Away Broadcom: Buy, Hold, Sell? AI & Acquistions Paint Strong Picture Hershey Hits the Sweet Spot for Defensive Investors A Bull Case for Adobe Stock Remains Today AMD Stock Signals Strong Buy Ahead of Earnings Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
